Patient demographics, disease activity at the time of image acquisition, and medications administered at the time of image acquisition. From 68 participants, 43 had 1 image evaluated, 18 had 2 images evaluated, and 7 had 3 images evaluated, for a total of 100 images. Values are mean (SD) unless otherwise specified.
| Characteristics | Values | Total Patients, n = 68 |
|---|---|---|
| Demographics | ||
| Female, n (%) | 48 (70.6) | 68* |
| White, n (%) | 56 (83.6) | 67* |
| Age, yrs** | 57.4 (10.3) | 66* |
| Weight, kg | 79.8 (17.6) | 63* |
| Height, cm | 167.5 (9.7) | 61* |
| Disease activity at time of image acquisition | Total Image Sets, n = 100 | |
| Symptom duration, yrs | 4.8 (4.5) | 97* |
| TJC28 | 6.7 (6.8) | 91* |
| SJC28 | 7.4 (6.0) | 91* |
| ESR, mm/h | 18.1 (14.7) | 85* |
| DAS28-ESR3V | 4.0 (1.5) | 83* |
| HAQ-DI | 0.64 (0.59) | 58* |
| Medications at time of image acquisition, n (%) | ||
| Oral steroid | 53 (53) | 100 |
| OTC medication | 83 (83) | 100 |
| DMARD | 87 (87) | 100 |
↵* Values are missing because of incomplete recording of information, laboratory tests not ordered, or incomplete questionnaire responses.
↵** Age when first image was taken. All patients imaged more than once had their last image taken no less than 6 months before and no later than 24 months after their first image. TJC28: tender joint count at 28 joints; SJC28: swollen joint count at 28 joints; ESR: erythrocyte sedimentation rate; DAS28-ESR3V: 3 variable Disease Activity Score (TJC, SJC, ESR); DAS28: DAS at 28 joints; HAQ-DI: Health Assessment Questionnaire–Disability Index; OTC: over-the-counter; DMARD: disease-modifying antirheumatic drugs.